USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$28.86 USD
-0.53 (-1.80%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $28.86 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
USNA 28.86 -0.53(-1.80%)
Will USNA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for USNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for USNA
Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now?
USANA Health (USNA) Upgraded to Buy: Here's Why
USNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
USNA or ZTS: Which Is the Better Value Stock Right Now?
Should Value Investors Buy Merck KGaA (MKKGY) Stock?
USANA Health Sciences (USNA) Q2 Earnings and Revenues Top Estimates
Other News for USNA
Insider Sell Alert: David Mulham Sells Shares of Usana Health Sciences Inc (USNA)
USANA Health Sciences: Hiya's Potential Is Showing
Usana Health Sciences Inc (USNA) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ...
Usana signals major compensation plan overhaul and product launches while repaying debt and achieving 11% sales growth
USANA Health Sciences, Inc. (USNA) Q2 2025 Earnings Call Transcript